AC
LH icon

Ascend Capital’s Labcorp LH Stock Holding History

Ascend Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-127,509
Closed -$14.1M – 158
2016
Q4 		$14.1M Buy
+127,509
New +$14.2M 0.7% 55
2015
Q2 		– Sell
-23,280
Closed -$2.52M – 177
2015
Q1 		$2.52M Sell
23,280
-172,107
-88% -$17.7M 0.09% 132
2014
Q4 		$18.1M Buy
+195,387
New +$17.3M 0.7% 52

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Ascend Capital's LH Position: Q1 2017 in Review

Ascend Capital sold out of Labcorp (LH) in Q1 2017, closing a stake of 127,509 shares — an estimated $14.1M sold.

Ascend Capital first reported a position in LH in Q4 2014 and held it in 3 quarters. The position peaked at $18.1M in Q4 2014. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

  • Ascend Capital reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
  • Ascend Capital sold 127,509 Labcorp shares in Q1 2017, an estimated $14.1M.
  • Ascend Capital first reported a position in Labcorp in Q4 2014 and held it in 3 quarters.
  • Ascend Capital's Labcorp position peaked at $18.1M in Q4 2014.
  • 693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on Ascend Capital's 13F filing for Q1 2017, filed 15 May 2017.